Top Markets
Coin of the day
Omnimmune Holdings, Inc. Omnimmune Holdings, Inc.

Omnimmune Holdings, Inc.

OMMH
Clasificación en acciones #42527
Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as... Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products, which target a hormone called human chorionic gonadotropin. In addition, the company plans to conduct a Phase I trial with its lead candidate anti-human chorionic gonadotropin beta subunit monoclonal antibodies based upon the results of the diagnostic trial. Omnimmune Holdings, Inc. is based in Houston, Texas.
Precio por acción
$0.0001
Última sincronización: 2026-07-17
Capitalización bursátil
$981.00
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Omnimmune Holdings, Inc. (OMMH)

Categoría

Historial del precio de la acción de Omnimmune Holdings, Inc. (OMMH)
Precio más alto de cierre: $0.00 el 2026-07-01

Precio más bajo de cierre: $0.00 el 2022-12-01
Historial del precio de la acción de Omnimmune Holdings, Inc. desde 2022 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.00%
2025 0.00%
2024 49.25%
2023 -33.00%
2022 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.08K -7.16%
KR